Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Morris, Daniel
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study	Active, not recruiting	4	313	Europe, US	Teprotumumab, TEPEZZA, Placebo, Saline Solution	Amgen	Thyroid Eye Disease	04/26	04/26
TEMPO, NCT04014179: Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs	Recruiting	N/A	2700	RoW	Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay	Kirby Institute	Hepatitis C, Hepatitis C, Chronic	12/25	12/25
Westwood, Hayley
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study	Active, not recruiting	4	313	Europe, US	Teprotumumab, TEPEZZA, Placebo, Saline Solution	Amgen	Thyroid Eye Disease	04/26	04/26